Cryoport, Inc. (CYRX)
CYRX Stock Price Chart
Explore Cryoport, Inc. interactive price chart. Choose custom timeframes to analyze CYRX price movements and trends.
CYRX Company Profile
Discover essential business fundamentals and corporate details for Cryoport, Inc. (CYRX) to support your stock research and investment decisions.
Sector
Industrials
Industry
Integrated Freight & Logistics
IPO Date
22 Aug 2005
Employees
1.09K
Website
https://www.cryoport.comCEO
Jerrell W. Shelton
Description
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
CYRX Financial Timeline
Browse a chronological timeline of Cryoport, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.23, while revenue estimate is $41.12M.
Earnings released on 5 Aug 2025
EPS came in at -$0.29 falling short of the estimated -$0.20 by -45.00%, while revenue for the quarter reached $45.45M , beating expectations by +9.39%.
Earnings released on 7 May 2025
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $41.04M , missing expectations by -3.26%.
Earnings released on 4 Mar 2025
EPS came in at -$0.42 falling short of the estimated -$0.33 by -27.27%, while revenue for the quarter reached $59.53M , beating expectations by +1.18%.
Earnings released on 7 Nov 2024
EPS came in at -$0.02 surpassing the estimated -$0.25 by +92.00%, while revenue for the quarter reached $56.66M , missing expectations by -3.62%.
Earnings released on 6 Aug 2024
EPS came in at -$0.33 surpassing the estimated -$0.37 by +10.81%, while revenue for the quarter reached $57.60M , missing expectations by -0.14%.
Earnings released on 7 May 2024
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%, while revenue for the quarter reached $54.59M , missing expectations by -7.09%.
Earnings released on 12 Mar 2024
EPS came in at -$0.51 falling short of the estimated -$0.32 by -59.38%, while revenue for the quarter reached $57.26M , missing expectations by -1.95%.
Earnings released on 8 Nov 2023
EPS came in at -$0.31 matching the estimated -$0.31, while revenue for the quarter reached $56.16M , beating expectations by +1.60%.
Earnings released on 9 Aug 2023
EPS came in at -$0.42 falling short of the estimated -$0.25 by -68.00%, while revenue for the quarter reached $57.02M , missing expectations by -3.94%.
Earnings released on 4 May 2023
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $62.82M , beating expectations by +1.07%.
Earnings released on 23 Feb 2023
EPS came in at -$0.24 falling short of the estimated -$0.21 by -14.29%, while revenue for the quarter reached $60.36M , beating expectations by +3.60%.
Earnings released on 3 Nov 2022
EPS came in at -$0.15 falling short of the estimated -$0.13 by -15.38%, while revenue for the quarter reached $60.46M , missing expectations by -13.56%.
Earnings released on 4 Aug 2022
EPS came in at -$0.17 falling short of the estimated -$0.15 by -13.33%, while revenue for the quarter reached $64.15M , missing expectations by -0.67%.
Earnings released on 5 May 2022
EPS came in at -$0.31 falling short of the estimated -$0.20 by -55.00%, while revenue for the quarter reached $52.30M , beating expectations by +0.06%.
Earnings released on 24 Feb 2022
EPS came in at -$1.32 falling short of the estimated -$0.15 by -780.00%, while revenue for the quarter reached $56.44M , missing expectations by -2.19%.
Earnings released on 4 Nov 2021
EPS came in at -$0.18 falling short of the estimated -$0.15 by -20.00%, while revenue for the quarter reached $56.69M , beating expectations by +3.68%.
Earnings released on 5 Aug 2021
EPS came in at -$0.16 falling short of the estimated -$0.13 by -23.08%, while revenue for the quarter reached $56.19M , meeting expectations.
Earnings released on 4 May 2021
EPS came in at -$0.13 surpassing the estimated -$0.21 by +38.10%, while revenue for the quarter reached $53.28M , missing expectations by -21.74%.
Earnings released on 1 Mar 2021
EPS came in at -$0.28 falling short of the estimated -$0.15 by -86.67%, while revenue for the quarter reached $48.36M .
Earnings released on 5 Nov 2020
EPS came in at -$0.29 falling short of the estimated -$0.13 by -123.08%, while revenue for the quarter reached $11.17M , beating expectations by +16.72%.
CYRX Stock Performance
Access detailed CYRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.